Correlation Between SoftwareONE Holding and COSMO Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SoftwareONE Holding and COSMO Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SoftwareONE Holding and COSMO Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SoftwareONE Holding AG and COSMO Pharmaceuticals SA, you can compare the effects of market volatilities on SoftwareONE Holding and COSMO Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SoftwareONE Holding with a short position of COSMO Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of SoftwareONE Holding and COSMO Pharmaceuticals.

Diversification Opportunities for SoftwareONE Holding and COSMO Pharmaceuticals

0.86
  Correlation Coefficient

Very poor diversification

The 3 months correlation between SoftwareONE and COSMO is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding SoftwareONE Holding AG and COSMO Pharmaceuticals SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COSMO Pharmaceuticals and SoftwareONE Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SoftwareONE Holding AG are associated (or correlated) with COSMO Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COSMO Pharmaceuticals has no effect on the direction of SoftwareONE Holding i.e., SoftwareONE Holding and COSMO Pharmaceuticals go up and down completely randomly.

Pair Corralation between SoftwareONE Holding and COSMO Pharmaceuticals

Assuming the 90 days trading horizon SoftwareONE Holding AG is expected to generate 1.28 times more return on investment than COSMO Pharmaceuticals. However, SoftwareONE Holding is 1.28 times more volatile than COSMO Pharmaceuticals SA. It trades about 0.18 of its potential returns per unit of risk. COSMO Pharmaceuticals SA is currently generating about 0.22 per unit of risk. If you would invest  499.00  in SoftwareONE Holding AG on April 21, 2025 and sell it today you would earn a total of  194.00  from holding SoftwareONE Holding AG or generate 38.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

SoftwareONE Holding AG  vs.  COSMO Pharmaceuticals SA

 Performance 
       Timeline  
SoftwareONE Holding 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in SoftwareONE Holding AG are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, SoftwareONE Holding showed solid returns over the last few months and may actually be approaching a breakup point.
COSMO Pharmaceuticals 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in COSMO Pharmaceuticals SA are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, COSMO Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

SoftwareONE Holding and COSMO Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SoftwareONE Holding and COSMO Pharmaceuticals

The main advantage of trading using opposite SoftwareONE Holding and COSMO Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SoftwareONE Holding position performs unexpectedly, COSMO Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COSMO Pharmaceuticals will offset losses from the drop in COSMO Pharmaceuticals' long position.
The idea behind SoftwareONE Holding AG and COSMO Pharmaceuticals SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Bonds Directory
Find actively traded corporate debentures issued by US companies